Conference Coverage
Latest News
Jun 04, 2026 | Commentary
The Emerging Role of Oral Peptide Therapeutics in Dermatology
Rese-cel Data Support Registrational Strategy Across Dermatomyositis, Systemic Sclerosis, Lupus
Jun 04, 2026
SkinJect Advances into Registrable Development as Potential First-in-Class Therapy for Gorlin Syndrome
Jun 03, 2026
Expert Consensus Offers Age-Specific Roadmap for Diagnosing Genital Psoriasis
Jun 03, 2026
Journal Digest: June 3, 2026
Jun 03, 2026
Videos
Advertisement
Shorts
0:23
Why Not All Microneedling Pens Are The Same
4 hours ago
by
Michael Gold, MD
1:00
Resources for Clinicians From the Melanoma Research Foundation
a day ago
by
Miriam Pomerantz Kadosh, MSW, LCSW
0:57
Soquelitinib May Offer New Oral Treatment for Patients With AD
2 days ago
by
Albert Chiou, MD, MBA
0:43
Why Rare Diseases Like EPP Are Frequently Misdiagnosed
3 days ago
by
Elizabeth Buzney, MD
1:00
Stop Calling Them Side Effects: Pro-Tips for Photodynamic Therapy
6 days ago
by
Neal Bhatia, MD
0:45
Why 86% of Patients Reported Feeling Better With This Hair Treatment
7 days ago
by
Maryanne Makredes Senna, MD
1:11
Celebrating National Sunscreen Day 2026
8 days ago
by
Whitney Hovenic, MD
0:39
When Should You Actually Use Patch Testing?
10 days ago
by
Patricia Delgado, DNP, AGPCNP, DCNP, PMHNP(+1 more)
0:59
The Sturge-Weber Foundation: Where Nobody Has to Hold Their Breath
10 days ago
by
Andrew C. Krakowski, MD(+2 more)
0:40
The Evolving Role of Biotech in Skin Care Manufacturing
14 days ago
by
Maxwell Stock
GEP-Guided Treatment for Melanoma & SCC Management
New Insights in Management of Moderate Hidradenitis Suppurativa
Discover Dermatology Times NP/PA Connect™!
Personalizing Treatment for Difficult Atopic Dermatitis Cases
Connect With Dermatology Times® Wherever You Scroll
Podcasts
Dermatology Times Digital Edition
Learn more about the in-depth topics covered in the May 2026 print issue of Dermatology Times.
Hadar Lev-Tov, MD, said one of the most rewarding aspects of treating HS is hearing patients say, “Doctor, you saved my life.”
Employment contracts can have enormous financial and career consequences, yet many clinicians review them too casually before signing.
Dermatologists are increasingly integrating AI into clinical workflows, though many still use it primarily as a search tool rather than a true care-support system.
Phase 3 data presented at AAD 2026 showed that amlitelimab significantly improved skin clearance and disease severity in patients aged 12 years and older with moderate to severe atopic dermatitis.
The growing success of IL-17–targeted therapies suggests that remission may become a realistic future goal for many patients living with hidradenitis suppurativa.
The proposed rule, first introduced in 2015, aimed to prohibit indoor tanning for individuals under 18 because of the known cancer risks associated with UV radiation.
Phages, or bacteriophages, are viruses that selectively infect bacteria and may offer a new way to treat bacterial skin diseases without antibiotics.
Biologics and oral JAK inhibitors are now strongly recommended for moderate to severe pediatric AD, signaling a shift toward earlier systemic treatment escalation.
Continuing Medical Education
All News
Advertisement
Advertisement
New IND pushes QRX003 toward first targeted therapy for peeling skin syndrome, with early pediatric results showing rapid healing and no safety issues.
Discover how oral GliSODin delivers SOD to boost skin defense, enhance retinoids, and reduce UV damage and dark spots—backed by clinical trials.
Unlock hidden dermatology revenue by tracking retention drop-offs, procedure sequencing, and device utilization—before collections reveal the leaks.
Unlike approved AD biologics and JAK inhibitors targeting specific cytokine pathways, GX-03 is designed to modulate inflammatory signaling locally within the skin microenvironment.
Explore top dermatology conferences and meetings in June 2026 and let us know which ones you'll be attending!
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.
Can misting hypochlorous acid every day improve skin, or is it just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
This month’s podcasts highlight the latest clinical insights, emerging therapies, and evolving conversations shaping dermatology practice.
Learn more about the in-depth topics covered in the May 2026 print issue of Dermatology Times.
Advertisement
Hadar Lev-Tov, MD, said one of the most rewarding aspects of treating HS is hearing patients say, “Doctor, you saved my life.”
Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.
Dermatology Times is looking back on the top stories in dermatology from the month of May.
Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of May.
Employment contracts can have enormous financial and career consequences, yet many clinicians review them too casually before signing.
Advertisement
Advertisement
Trending on Dermatology Times
1
STAT6 Degradation by KT-621 Correlates With Itch and Lesion Reduction in AD
2
Dermalogica Enters Medical Aesthetics with FDA-Cleared Microneedling PRO Pen
3
SkinJect Advances into Registrable Development as Potential First-in-Class Therapy for Gorlin Syndrome
4
Quoin Submits First-Ever IND Application for Peeling Skin Syndrome Therapy
5